Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of alendronate in prevention of steroid-induced osteopenia in childhood ALL and NHL
IRCT201202279155N1Phase 3Completed
- Sponsor
- Vice chancellor for research,Arak University of Medical Sciences
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of alendronate in osteoporosis and osteopenia, sponsored by Vice chancellor for research,Arak University of Medical Sciences. Started Apr 2012; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on IRCT201202279155N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201202279155N1.